Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

GH secretion status in myotonic dystrophy

J M Gómez-Sáez1, J M Fernández-Real, M A Navarro

  • 1Endocrine Department, Hospital de Bellvitge, Universidad de Barcelona, Spain.

Psychoneuroendocrinology
|January 1, 1993
PubMed
Summary

Myotonic dystrophy (MD) patients show impaired growth hormone (GH) secretion compared to healthy individuals. However, GH release can be stimulated by insulin-induced hypoglycemia or pyridostigmine pretreatment in some MD patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of dietary phosphorus and calcium depletion-repletion on pig performance and bone quality.

Animal : an international journal of animal bioscience·2026
Same author

Bones, reproductive organs and carcass characteristics of entire, early and late immunocastrated male pigs.

Animal : an international journal of animal bioscience·2025
Same author

Acidification and solar drying of manure-based digestate to produce improved fertilizing products.

Journal of environmental management·2023
Same author

Mechanotransduction in tumor dynamics modeling.

Physics of life reviews·2023
Same author

Dysregulation of macrophage PEPD in obesity determines adipose tissue fibro-inflammation and insulin resistance.

Nature metabolism·2022
Same author

Obesity status and obesity-associated gut dysbiosis effects on hypothalamic structural covariance.

International journal of obesity (2005)·2021

Area of Science:

  • Endocrinology
  • Genetics
  • Neurology

Background:

  • Myotonic dystrophy (MD) is associated with endocrine dysfunctions, including abnormal growth hormone (GH) secretion.
  • Understanding GH secretion patterns is crucial for managing metabolic and growth disturbances in MD.

Purpose of the Study:

  • To investigate GH secretion status in MD patients.
  • To evaluate GH response to growth hormone-releasing hormone (GHRH) and insulin-induced hypoglycemia.
  • To assess the effect of pyridostigmine on GHRH-stimulated GH release in MD.

Main Methods:

  • GH response to GHRH (100 µg) was measured in MD patients and controls.
  • GH response to insulin-induced hypoglycemia was assessed.
  • The effect of pyridostigmine pretreatment on GHRH-stimulated GH release was evaluated in MD patients.

Related Experiment Videos

  • Insulin-like growth factor I (IGF-I) levels were measured.

    • Main Results:

    • MD patients exhibited significantly lower peak GH response to GHRH compared to normal controls (11.4 vs. 27.8 µg/l).
    • Five out of seven MD patients showed a higher GH peak after insulin-induced hypoglycemia than after GHRH.
    • Pyridostigmine pretreatment potentiated GHRH-induced GH release in MD patients (17.6 vs. 10.05 µg/l).
    • IGF-I levels were normal in all tested MD patients.

    Conclusions:

    • GH secretion is impaired in MD patients, as indicated by blunted responses to GHRH.
    • GH release in response to hypoglycemia or GHRH with pyridostigmine may be preserved in some MD patients.
    • These findings suggest a potential role for therapeutic interventions targeting GH secretion in MD.